US 6,515,016 B2Granted

Composition and methods of paclitaxel for treating psoriasis

AssigneeAngiotech Pharmaceuticals, Inc.

InventorWilliam L. Hunter

Life of this patent

Estimating the term…

Abstract

The present invention provides methods for treating or preventing inflammatory diseases such as psoriasis or multiple sclerosis, comprising the step of delivering to the site of inflammation an anti-microtubule agent, or analogue or derivative thereof.

Claims28

Dependent claims

A method for treating or preventing psoriasis, comprising administering to a patient in need thereof a therapeutically effective amount of an anti-microtubule agent, wherein said anti-microtubule agent is paclitaxel, or an analogue or derivative thereof, such that said psoriasis is treated or prevented.

Dependencies are inferred from the claim text.

Facts

Application: 08/980,549Filed 1 Dec 1997 · us provisional application
Priority: 2 Dec 1996
Published: US 2002/0037919 A128 Mar 2002
Granted: 4 Feb 2003
Term ends: Not estimatedThe source records don’t support an estimate.

Classification66 codes

A61K 47/6957
The conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit: the form being a…
A61K 9/0014
Galenical forms characterised by the site of application: skin, i.e. galenical aspects of topical compositions
A61K 9/0019
Galenical forms characterised by the site of application: injectable compositions; Intramuscular, intravenous, arterial, subcutaneous…
A61K 9/0048
Galenical forms characterised by the site of application: eye, e.g. artificial tears

Family

Application60/032,215Us provisional application · filed 2 Dec 1996
Application60/063,087Us provisional application · filed 24 Oct 1997
US 2002/0037919 A1Pre-grant publication · published 28 Mar 2002
US 6,515,016 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results